INNT
TOTAL INVALIDATION PROCESSED BY THE IB
22/11/2025
Voltar para busca
Dado oficial do USPTO
CARBAPLEX
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
CARBAPLEX
ST13
US500000079191767Classe
1, 5, 10, 42
Pedido
79191767
Registro
5430364
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
46
Atualização mais recente
23/11/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 10, 42
Data de depósito
14/03/2016
Data de registro
27/03/2018
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
11/10/2024
Última transação
23/11/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
Coventry CV4 9GH, GB
Examinador
MALYSZEK,KIMBERLY RAY
Unidade examinadora
N40
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Bruker UK Limited
Bruker UK Limited
Renishaw Diagnostics Ltd
Representantes
Philip Conrad Benoît & Côté, Inc.
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 10Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Diagnostic reagents for scientific use; chemical reagents for use in analytical testsother than for medical or veterinary use; chemical reagents for use in diagnosisother than for medical or veterinary use; diagnostic reagents for scientific use or research; diagnostic preparations for scientific use; diagnostic kits consisting primarily of reagents for scientific and research use to identify multiple causative agents ofbiomarkers involved inhuman disease; mixtures consisting primarily of chemical reagentsother than for medical or veterinary use; mixtures consisting primarily of chemical reagents in a kit for scientific laboratory useother than for medical or veterinary use; chemicals and chemical reagents for use in industryscience and researchchemical solutions and preparations consisting of pre-mixed reactants and reagents for scientific and research use in connection with identification of multiple causative agents ofbiomarkers involved inhuman disease; mixtures consisting primarily of chemical reagents in a kit for scientific laboratory useother than for medical or veterinary purpose suitable for use with Raman SpectroscopySurface Enhanced Raman Scattering (SERS) and Surface Enhanced Resonance Raman Scattering (SERRS)
Classe 5
Reagents for medical diagnostic use
Classe 10
Medical devices and instrumentsconsisting of testing kits for medical usediagnostic kits consisting primarily of probesbufferschemicals and chemical reagents for use in Raman SpectroscopySurface Enhanced Raman Scattering (SERS) and Surface Enhanced Resonance Raman Scattering (SERRS)not drug delivery systems for medical use; medical testing instruments for diagnostic useapparatus for medical diagnostic testing in the fields of identification of multiple causative agents ofand/or biomarkers involved inhuman diseasenot drug delivery systems for medical use; in-vitro diagnostic testing apparatus and also incorporating solutions and preparations consisting of pre-mixed reactants and biochemical reagentsspecifically adapted for medical usenot drug delivery systems for medical use; in-vitro diagnostic testing apparatus and also incorporating chemical reagentsspecifically adapted for medical usenot drug delivery systems for medical use
Classe 42
Medical and scientific research in the field of configurationfault diagnosis of sample analyzers and sample processors for use with chemical reagent mixtures
Publicações
Histórico de despachos e eventos da marca no USPTO.
46 publicações encontradas
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
03/11/2025
INPC
INVALIDATION PROCESSED
03/11/2025
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
11/06/2025
C71T
CANCELLED SECTION 71
11/10/2024
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
27/03/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/11/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/11/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/11/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/11/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
02/11/2020
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/08/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/07/2018
FIMP
FINAL DISPOSITION PROCESSED
09/07/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
27/06/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
27/03/2018
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
09/03/2018
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
22/02/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
21/02/2018
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
21/02/2018
CHLD
CHANGE OF OWNER RECEIVED FROM IB
31/08/2017
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
07/07/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
23/05/2017
PUBO
PUBLISHED FOR OPPOSITION
23/05/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/05/2017
CHLD
CHANGE OF OWNER RECEIVED FROM IB
13/04/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/04/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
10/04/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/04/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
10/04/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/04/2017
NREP
NEW REPRESENTATIVE AT IB RECEIVED
31/03/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
28/03/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
28/03/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
28/03/2017
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
24/01/2017
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
24/01/2017
RFNP
REFUSAL PROCESSED BY IB
21/10/2016
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
30/09/2016
RFRR
REFUSAL PROCESSED BY MPU
30/09/2016
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
24/09/2016
CNRT
NON-FINAL ACTION WRITTEN
23/09/2016
MAFR
APPLICATION FILING RECEIPT MAILED
23/09/2016
DOCK
ASSIGNED TO EXAMINER
19/09/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
19/09/2016
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
15/09/2016
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CARBAPLEX ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.